About the Amsterdam Immunogenicity & Tolerance Seminar:
Time: 9am – 5pm European Time (A cocktail reception will immediately follow the meeting from 5 – 7pm)
The 10th annual Amsterdam Immunogenicity & Tolerance Seminar will showcase talks from expert biologics and vaccine developers from industry and academia highlighting how immunogenicity and tolerance have played a role in their recent work.
Speakers for this year include visionaries from Leiden University Medical Centre, Pfizer, Inc., Utrecht University, EpiVax, Inc., and more. Topics will cover updates on the preclinical and clinical development of tolerance-inducing therapies for autoimmune diseases, immunogenicity assessment strategies and case studies for selection of optimal biologics and vaccines, and updates on how to address hyporesponsiveness and off-target effects of vaccines.
In addition to the talks, there will be networking opportunities, poster presentations, and more.
As a leader in the field of preclinical immunogenicity assessment, design, and optimization of biologics and vaccines, in addition to a developer of a tolerance-inducing therapy, EpiVax hosts this seminar to connect with Europe-based collaborators and to bring industry and academic experts together to share new ideas and present research updates in the space.
Speakers:
Annie De Groot, M.D., EpiVax
Sarah Moniz, EpiVax
Sophie Tourdot, Ph.D., Pfizer, Inc.
Charlotte Fribert, Ph.D., Toleranzia
Femke Broere, Ph.D., Utrecht University
Prof. Peter Aaby, DMSc, University of Southern Denmark
Prof. Mihai Netea, M.D., Radbound University Medical Center
Mariatheresa Coppola, M.D., Ph.D, Leiden University Medical Center
Source: EpicVax